20,862
edits
Changes
Jump to navigation
Jump to search
→RCT in Kenya: Revise text.
}}</ref>Of the three {{#tip-text:RCT|Randomized controlled trial}}s being used by the [[WHO]] to endorse circumcision as HIV prevention, Stephen Moses and [[Robert C. Bailey]] headed the {{#tip-text:RCT|Randomized controlled trial}} that was carried out in Kenya.<ref>Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. ''Lancet'' 2007;369:643-56. [http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(07)60312-2/abstract Abstract]</ref> Moses obviously brought his pre-existing bias in favor of male circumcision into the trial, so he did not start from a neutral position.
Moses' research on circumcision protection from HIV infection is now completely discredited. Boyle & Hill (2011) reviewed the three randomized controlled trials (RCTs) and found disabling methodological and statistical errors in all three. Although a 60 percent ''relative'' reduction in HIV was claimed, the ''absolute'' reduction was a statistically insignificant 1.3 percent.<ref name="boyle-hill2011">{{REFjournal
|last=Boyle
|first=Gregory J.
|DOI=
|accessdate=2020-03-23
}}</ref> Garenne & Matthews (2019) report that circumcised men have as much HIV infection as intact men.<ref>{{REFjournal
|last=Garenne
|first=M
|author-link=
|last2=Matthews
|first2=A
|author2-link=
|etal=no
|title=Voluntary medical male circumcision and HIV in Zambia: expectations and observations
|trans-title=
|language=
|journal=J Biosoc Science
|location=
|date=2019-10-01
|volume=14
|issue=
|pages=1-13
|url=
|quote=
|pubmedID=31608845
|pubmedCID=
|DOI=10.1017/S0021932019000634
|accessdate=2020-03-25
}}</ref>